T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
78 hedge funds and large institutions have $34.6M invested in T2 Biosystems, Inc in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 9 closing their positions.
56% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 9
21% more call options, than puts
Call options by funds: $659K | Put options by funds: $546K
7% more funds holding
Funds holding: 73 → 78 (+5)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
19% less capital invested
Capital invested by funds: $42.6M → $34.6M (-$8.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.01M |
| 2 |
Millennium Management
New York
|
+$1.27M |
| 3 |
State Street
Boston,
Massachusetts
|
+$600K |
| 4 |
GS
Gagnon Securities
New York
|
+$355K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$252K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$956K |
| 2 |
HF
HRT Financial
New York
|
-$529K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$356K |
| 4 |
Two Sigma Advisers
New York
|
-$355K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$252K |
TTOO Hedge Fund Activity: Q2 2021 in Review
78 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2021, worth a combined $34.6M — down 19% from $42.6M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TTOO positions and 9 closed out — a net gain of 5 holders — while 13 added to existing stakes and 16 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $2.01M. The largest seller was Two Sigma Investments, cutting an estimated $956K.
- 78 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2021, up from 73 in Q1 2021.
- Funds reported $34.6M of T2 Biosystems, Inc stock for Q2 2021, down 19% quarter-over-quarter.
- 14 funds opened new T2 Biosystems, Inc positions in Q2 2021 and 9 closed out, a net change of +5 holders.
- The largest T2 Biosystems, Inc buyer in Q2 2021 was Renaissance Technologies, an estimated $2.01M added.
- The largest T2 Biosystems, Inc seller in Q2 2021 was Two Sigma Investments, an estimated $956K sold.
Based on aggregated 13F filings for Q2 2021.